A variant of the sigma receptor type 1 gene is a protective factor for Alzheimer’s disease.

Selective M1 muscarinic agonists: failure of therapeutic strategy against Alzheimer’s disease or inappropriate tactics?

Oxidative Damage Is the Earliest Event in Alzheimer Disease

Animal models of Alzheimer’s disease and evaluation of anti-dementia drugs.

Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer’s disease correlates with CA1 pyramidal cell loss.